- Home
- CRBU vs MODV Comparison
CRBU vs MODV Comparison
Compare CRBU & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- MODV
- Stock Information
- Founded
- CRBU 2011
- MODV 1996
- Country
- CRBU United States
- MODV United States
- Employees
- CRBU N/A
- MODV N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- MODV Transportation Services
- Sector
- CRBU Health Care
- MODV Consumer Discretionary
- Exchange
- CRBU Nasdaq
- MODV Nasdaq
- Market Cap
- CRBU 93.0M
- MODV 81.8M
- IPO Year
- CRBU 2021
- MODV N/A
- Fundamental
- Price
- CRBU $0.95
- MODV $1.40
- Analyst Decision
- CRBU Strong Buy
- MODV Buy
- Analyst Count
- CRBU 5
- MODV 4
- Target Price
- CRBU $11.80
- MODV $8.38
- AVG Volume (30 Days)
- CRBU 1.0M
- MODV 545.7K
- Earning Date
- CRBU 03-10-2025
- MODV 03-06-2025
- Dividend Yield
- CRBU N/A
- MODV N/A
- EPS Growth
- CRBU N/A
- MODV N/A
- EPS
- CRBU N/A
- MODV N/A
- Revenue
- CRBU $9,994,000.00
- MODV $2,787,586,000.00
- Revenue This Year
- CRBU $3.50
- MODV $4.79
- Revenue Next Year
- CRBU $177.84
- MODV $6.98
- P/E Ratio
- CRBU N/A
- MODV N/A
- Revenue Growth
- CRBU N/A
- MODV 1.32
- 52 Week Low
- CRBU $0.88
- MODV $1.38
- 52 Week High
- CRBU $5.15
- MODV $32.82
- Technical
- Relative Strength Index (RSI)
- CRBU 40.45
- MODV 23.16
- Support Level
- CRBU $0.88
- MODV $1.68
- Resistance Level
- CRBU $1.01
- MODV $2.26
- Average True Range (ATR)
- CRBU 0.08
- MODV 0.29
- MACD
- CRBU 0.01
- MODV 0.04
- Stochastic Oscillator
- CRBU 42.00
- MODV 1.13
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.